Medicina Interna, Dermatología y Psiquiatría
Departamento
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (45)
2024
-
Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis
HemaSphere
-
Repercussion of psoriasis on the emotional health, well-being and quality of life of patients: A descriptive cross-sectional study
Piel, Vol. 39, Núm. 4, pp. 185-192
-
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
American Journal of Hematology
2023
-
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain
Annals of Hematology, Vol. 102, Núm. 2, pp. 447-456
2022
-
ANTES Program: One Year on
Archivos de Bronconeumologia
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years
ERJ Open Research, Vol. 8, Núm. 4
-
Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome
Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 159-170
-
Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD
Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 69-81
-
[Translated article] ANTES Program: One Year on
Archivos de Bronconeumologia
-
[Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. T334-T344
2021
-
Predictors of clinically significant quality of life impairment in Parkinson’s disease
npj Parkinson's Disease, Vol. 7, Núm. 1
-
Prevalence and Determinants of COPD in Spain: EPISCAN II
Archivos de bronconeumologia, Vol. 57, Núm. 1, pp. 61-69
-
Prevalence and Determinants of COPD in Spain: EPISCAN II
Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 61-69
-
Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
Archivos de Bronconeumologia
-
Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
Archivos de Bronconeumologia
2020
-
Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data
ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10
-
Phenotypic characterisation of early copd: A prospective case–control study
ERJ Open Research, Vol. 6, Núm. 4, pp. 1-13
2019
-
10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain —A Summary of the EPISCAN II Protocol
Archivos de Bronconeumologia, Vol. 55, Núm. 1, pp. 38-47
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation
European Journal of Neurology, Vol. 26, Núm. 11, pp. 1399-1407